Literature DB >> 23055555

Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1.

Jonathan M Carlson1, Chanson J Brumme, Eric Martin, Jennifer Listgarten, Mark A Brockman, Anh Q Le, Celia K S Chui, Laura A Cotton, David J H F Knapp, Sharon A Riddler, Richard Haubrich, George Nelson, Nico Pfeifer, Charles E Deziel, David Heckerman, Richard Apps, Mary Carrington, Simon Mallal, P Richard Harrigan, Mina John, Zabrina L Brumme.   

Abstract

HLA class I-associated polymorphisms identified at the population level mark viral sites under immune pressure by individual HLA alleles. As such, analysis of their distribution, frequency, location, statistical strength, sequence conservation, and other properties offers a unique perspective from which to identify correlates of protective cellular immunity. We analyzed HLA-associated HIV-1 subtype B polymorphisms in 1,888 treatment-naïve, chronically infected individuals using phylogenetically informed methods and identified characteristics of HLA-associated immune pressures that differentiate protective and nonprotective alleles. Over 2,100 HLA-associated HIV-1 polymorphisms were identified, approximately one-third of which occurred inside or within 3 residues of an optimally defined cytotoxic T-lymphocyte (CTL) epitope. Differential CTL escape patterns between closely related HLA alleles were common and increased with greater evolutionary distance between allele group members. Among 9-mer epitopes, mutations at HLA-specific anchor residues represented the most frequently detected escape type: these occurred nearly 2-fold more frequently than expected by chance and were computationally predicted to reduce peptide-HLA binding nearly 10-fold on average. Characteristics associated with protective HLA alleles (defined using hazard ratios for progression to AIDS from natural history cohorts) included the potential to mount broad immune selection pressures across all HIV-1 proteins except Nef, the tendency to drive multisite and/or anchor residue escape mutations within known CTL epitopes, and the ability to strongly select mutations in conserved regions within HIV's structural and functional proteins. Thus, the factors defining protective cellular immune responses may be more complex than simply targeting conserved viral regions. The results provide new information to guide vaccine design and immunogenicity studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23055555      PMCID: PMC3503140          DOI: 10.1128/JVI.01998-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  119 in total

1.  Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.

Authors:  K C Parker; M A Bednarek; L K Hull; U Utz; B Cunningham; H J Zweerink; W E Biddison; J E Coligan
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

2.  Motif inference reveals optimal CTL epitopes presented by HLA class I alleles highly prevalent in southern Africa.

Authors:  Isobella Honeyborne; Almas Rathod; Rico Buchli; Dhanwanthie Ramduth; Eshia Moodley; Prinisha Rathnavalu; Senica Chetty; Cheryl Day; Christian Brander; William Hildebrand; Bruce D Walker; Photini Kiepiela; Philip J R Goulder
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

3.  Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs.

Authors:  Mina John; David Heckerman; Ian James; Lawrence P Park; Jonathan M Carlson; Abha Chopra; Silvana Gaudieri; David Nolan; David W Haas; Sharon A Riddler; Richard Haubrich; Simon Mallal
Journal:  J Immunol       Date:  2010-03-15       Impact factor: 5.422

4.  Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.

Authors:  Sampa Santra; Hua-Xin Liao; Ruijin Zhang; Mark Muldoon; Sydeaka Watson; Will Fischer; James Theiler; James Szinger; Harikrishnan Balachandran; Adam Buzby; David Quinn; Robert J Parks; Chun-Yen Tsao; Angela Carville; Keith G Mansfield; George N Pavlakis; Barbara K Felber; Barton F Haynes; Bette T Korber; Norman L Letvin
Journal:  Nat Med       Date:  2010-02-21       Impact factor: 53.440

5.  Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.

Authors:  Morgane Rolland; Sodsai Tovanabutra; Allan C deCamp; Nicole Frahm; Peter B Gilbert; Eric Sanders-Buell; Laura Heath; Craig A Magaret; Meera Bose; Andrea Bradfield; Annemarie O'Sullivan; Jacqueline Crossler; Teresa Jones; Marty Nau; Kim Wong; Hong Zhao; Dana N Raugi; Stephanie Sorensen; Julia N Stoddard; Brandon S Maust; Wenjie Deng; John Hural; Sheri Dubey; Nelson L Michael; John Shiver; Lawrence Corey; Fusheng Li; Steve G Self; Jerome Kim; Susan Buchbinder; Danilo R Casimiro; Michael N Robertson; Ann Duerr; M Juliana McElrath; Francine E McCutchan; James I Mullins
Journal:  Nat Med       Date:  2011-02-27       Impact factor: 53.440

6.  Progression to AIDS in South Africa is associated with both reverting and compensatory viral mutations.

Authors:  Kuan-Hsiang Gary Huang; Dominique Goedhals; Jonathan M Carlson; Mark A Brockman; Swati Mishra; Zabrina L Brumme; Stephen Hickling; Christopher S W Tang; Toshiyuki Miura; Chris Seebregts; David Heckerman; Thumbi Ndung'u; Bruce Walker; Paul Klenerman; Dewald Steyn; Philip Goulder; Rodney Phillips; Cloete van Vuuren; John Frater
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

7.  The IMGT/HLA database.

Authors:  James Robinson; Kavita Mistry; Hamish McWilliam; Rodrigo Lopez; Peter Parham; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2010-11-11       Impact factor: 16.971

8.  HLA class I supertypes: a revised and updated classification.

Authors:  John Sidney; Bjoern Peters; Nicole Frahm; Christian Brander; Alessandro Sette
Journal:  BMC Immunol       Date:  2008-01-22       Impact factor: 3.615

9.  Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA.

Authors:  Alasdair Leslie; Daniel Kavanagh; Isobella Honeyborne; Katja Pfafferott; Charles Edwards; Tilly Pillay; Louise Hilton; Christina Thobakgale; Danni Ramduth; Rika Draenert; Sylvie Le Gall; Graz Luzzi; Anne Edwards; Christian Brander; Andrew K Sewell; Sarah Moore; James Mullins; Corey Moore; Simon Mallal; Nina Bhardwaj; Karina Yusim; Rodney Phillips; Paul Klenerman; Bette Korber; Photini Kiepiela; Bruce Walker; Philip Goulder
Journal:  J Exp Med       Date:  2005-03-21       Impact factor: 14.307

10.  Coping with viral diversity in HIV vaccine design.

Authors:  David C Nickle; Morgane Rolland; Mark A Jensen; Sergei L Kosakovsky Pond; Wenjie Deng; Mark Seligman; David Heckerman; James I Mullins; Nebojsa Jojic
Journal:  PLoS Comput Biol       Date:  2007-04-27       Impact factor: 4.475

View more
  70 in total

1.  Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic.

Authors:  Natalie N Kinloch; Daniel R MacMillan; Anh Q Le; Laura A Cotton; David R Bangsberg; Susan Buchbinder; Mary Carrington; Jonathan Fuchs; P Richard Harrigan; Beryl Koblin; Margot Kushel; Martin Markowitz; Kenneth Mayer; M J Milloy; Martin T Schechter; Theresa Wagner; Bruce D Walker; Jonathan M Carlson; Art F Y Poon; Zabrina L Brumme
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

2.  Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.

Authors:  Ming-Han Chloe Tsai; Supriya Singh; Emily Adland; Philip Goulder
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

3.  Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1.

Authors:  Christoph T Berger; Anuska Llano; Jonathan M Carlson; Zabrina L Brumme; Mark A Brockman; Samandhy Cedeño; P Richard Harrigan; Daniel E Kaufmann; David Heckerman; Andreas Meyerhans; Christian Brander
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

4.  Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity.

Authors:  Natalie N Kinloch; Guinevere Q Lee; Jonathan M Carlson; Steven W Jin; Chanson J Brumme; Helen Byakwaga; Conrad Muzoora; Mwebesa B Bwana; Kyle D Cobarrubias; Peter W Hunt; Jeff N Martin; Mary Carrington; David R Bangsberg; P Richard Harrigan; Mark A Brockman; Zabrina L Brumme
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

5.  HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers.

Authors:  Radwa Sharaf; Guinevere Q Lee; Xiaoming Sun; Behzad Etemad; Layla M Aboukhater; Zixin Hu; Zabrina L Brumme; Evgenia Aga; Ronald J Bosch; Ying Wen; Golnaz Namazi; Ce Gao; Edward P Acosta; Rajesh T Gandhi; Jeffrey M Jacobson; Daniel Skiest; David M Margolis; Ronald Mitsuyasu; Paul Volberding; Elizabeth Connick; Daniel R Kuritzkes; Michael M Lederman; Xu G Yu; Mathias Lichterfeld; Jonathan Z Li
Journal:  J Clin Invest       Date:  2018-08-20       Impact factor: 14.808

Review 6.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.

Authors:  Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

7.  Rare Control of SIVmac239 Infection in a Vaccinated Rhesus Macaque.

Authors:  Mauricio A Martins; Damien C Tully; Young C Shin; Lucas Gonzalez-Nieto; Kim L Weisgrau; David J Bean; Rujuta Gadgil; Martin J Gutman; Aline Domingues; Helen S Maxwell; Diogo M Magnani; Michael Ricciardi; Nuria Pedreño-Lopez; Varian Bailey; Michael A Cruz; Noemia S Lima; Myrna C Bonaldo; John D Altman; Eva Rakasz; Saverio Capuano; Keith A Reimann; Michael Piatak; Jeffrey D Lifson; Ronald C Desrosiers; Todd M Allen; David I Watkins
Journal:  AIDS Res Hum Retroviruses       Date:  2017-06-29       Impact factor: 2.205

8.  Host-specific adaptation of HIV-1 subtype B in the Japanese population.

Authors:  Takayuki Chikata; Jonathan M Carlson; Yoshiko Tamura; Mohamed Ali Borghan; Takuya Naruto; Masao Hashimoto; Hayato Murakoshi; Anh Q Le; Simon Mallal; Mina John; Hiroyuki Gatanaga; Shinichi Oka; Zabrina L Brumme; Masafumi Takiguchi
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

9.  Early Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment.

Authors:  Gabriela Turk; Yanina Ghiglione; Juliana Falivene; María Eugenia Socias; Natalia Laufer; Romina Soledad Coloccini; Ana María Rodriguez; María Julia Ruiz; María Ángeles Pando; Luis David Giavedoni; Pedro Cahn; Omar Sued; Horacio Salomon; María Magdalena Gherardi
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

10.  Significant reductions in Gag-protease-mediated HIV-1 replication capacity during the course of the epidemic in Japan.

Authors:  Shigeru Nomura; Noriaki Hosoya; Zabrina L Brumme; Mark A Brockman; Tadashi Kikuchi; Michiko Koga; Hitomi Nakamura; Tomohiko Koibuchi; Takeshi Fujii; Jonathan M Carlson; David Heckerman; Ai Kawana-Tachikawa; Aikichi Iwamoto; Toshiyuki Miura
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.